Pricing Log in Create free account
Friday 6 November 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.

Revenue
+5.86%
EPS
−95.8%
Free cash flow
−21.4%
Total debt
−9.16%

Quarter to September 2026, against a year earlier

272.44 3.88 −1.40%
Market cap
$655.6B
P/E
41.3×
Fwd P/E
40.0×
Dividend yield
1.94%
F-score
3/9
Altman Z
4.78
Beneish M
−2.26
Dividend safety
78/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Johnson & Johnson (JNJ) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Johnson & Johnson (JNJ) trades at a P/B ratio of 8.1×. Over the past ten years it has ranged from 3.5× (August 2015) to 8.2× (November 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 5.2× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.1× 25.46%
FY2024 4.9× (17.36%)
FY2023 5.9× (3.24%)
FY2022 6.1× 0.13%
FY2021 6.1× (7.10%)
FY2020 6.5× 0.93%
FY2019 6.5× 12.03%
FY2018 5.8× (7.04%)
FY2017 6.2× 42.98%
FY2016 4.4× 9.51%

Quarterly newest first

Period P/B ratio Change
Sep 2026 7.8× 8.74%
Jun 2026 7.2× (0.78%)
Mar 2026 7.3× 18.70%
Dec 2025 6.1× 8.47%
43 more quarters

Against its own ten years

Low 3.5× High 8.2×
Ten-year median 5.7×
Current reading's percentile 100

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. compare n/m
PFE Pfizer Inc. compare 1.9×
AZN AstraZeneca PLC compare 5.6×
JNJ Johnson & Johnson 8.1×
NVS Novartis AG compare 8.2×
MRK Merck & Co., Inc. compare 8.6×
GILD Gilead Sciences, Inc. compare 16.1×
AMGN Amgen Inc. compare 21.4×
LLY Eli Lilly and Company compare 30.3×
Drug Manufacturers General industry median 5.2×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on JNJ